News

New Drugs, Approaches Offer Hope Against Prostate Cancer04-Mar-2010
WEDNESDAY, March 3 (HealthDay News) -- Scientists are making headway in finding ways to treat and detect stubborn forms of prostate cancer.

Pre-Diagnosis Diet Linked to Ovarian Cancer Survival04-Mar-2010
THURSDAY, March 4 (HealthDay News) -- Healthy eating habits lead to longer survival for ovarian cancer patients, U.S. researchers say.

Radiation Most Effective Soon After Breast Cancer Surgery04-Mar-2010
THURSDAY, March 4 (HealthDay News) -- For women who have had breast cancer surgery, the question of whether or not to wait before receiving radiation therapy has been answered by new research that suggests that the longer women wait, the greater the chance of cancer recurrence.

Preventive Mastectomy in Opposite Breast Boosts Survival Only Slightly25-Feb-2010
THURSDAY, Feb. 25 (HealthDay News) -- Women with breast cancer who choose to have a preventive mastectomy on their disease-free breast do reduce their risk of cancer in that breast, studies have shown.

Removing Lymph Nodes May Boost Endometrial Cancer Survival25-Feb-2010
THURSDAY, Feb. 25 (HealthDay News) -- Endometrial cancer patients at medium to high risk for cancer recurrence are more likely to survive if both the pelvic lymph nodes and para-aortic lymph nodes are removed, rather than just the pelvic lymph nodes, say Japanese researchers.

Third of Young U.S. Adults Lack Health Insurance24-Feb-2010
WEDNESDAY, Feb. 24 (HealthDay News) -- Almost one-third of young adults in their 20s lacked health insurance in the United States in 2008, new statistics show.

Access to Mammograms Drops After Guidelines Change23-Feb-2010
TUESDAY, Feb. 23 (HealthDay News) -- In some states, access to mammograms for women ages 40 to 49 has decreased since new breast cancer screening guidelines were released in November by the U.S. Preventive Services Task Force, according to a new survey.

Dips in Breast Cancer Rates Seen Most in Affluent Women19-Feb-2010
FRIDAY, Feb. 19 (HealthDay News) -- Breast cancer rates are declining, especially among women over 50 who have estrogen receptor-positive tumors, and now a new study narrows down the reason why.

Rituxan Approved for Chronic Lymphocytic Leukemia19-Feb-2010
FRIDAY, Feb. 19 (HealthDay News) -- Rituxan (rituximab) has been approved by the U.S. Food and Drug Administration to treat a slowly progressing form of blood and bone marrow cancer known as chronic lymphocytic leukemia (CLL), the agency said in a press release.

Scientists Spot Genetic 'Fingerprints' of Individual Cancers18-Feb-2010
THURSDAY, Feb. 18 (HealthDay News) -- Researchers have found a way to analyze the "fingerprint" of a cancer, and then use that fingerprint to track the trajectory of that particular tumor in that particular person.